SCHEMBL9290653

SCHEMBL9290653

COc1cc(CNS(=O)(=O)c2ccc(C)s2)nc(-c2ccccn2)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
PKM P14618 1/20 0.48
GAA P10253 3/20 0.46
TSHR P16473 2/20 0.46
IL1RN P18510 1/20 0.44
ERAP2 Q6P179 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
TP53 P04637 2/20 0.41
THRB P10828 1/20 0.41
HSP90AA1 P07900 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9290536 0.91 KDM4E (0.54) KDM4EPKMGAATSHRIL1RN
SCHEMBL9290554 0.89 TSHR (0.61) KDM4EPKMGAATSHRIL1RN
SCHEMBL9290541 0.89 TP53 (0.52) KDM4EPKMGAATSHRIL1RN
SCHEMBL9290572 0.85 KDM4E (0.43) KDM4EPKMGAATSHRIL1RN
SCHEMBL9290544 0.85 CCNE1 (0.43) KDM4EPKMGAATSHRIL1RN
SCHEMBL17850523 0.85 TP53 (0.45) KDM4ETP53SMN1; SMN2LMNAHTT
SCHEMBL17850494 0.85 PKM (0.49) KDM4EPKMGAATSHRTP53
SCHEMBL17850493 0.85 NPY5R (0.49) KDM4EPKMTP53SMN1; SMN2LMNA
SCHEMBL9290624 0.84 TP53 (0.45) KDM4EPKMGAATSHRIL1RN
SCHEMBL9290576 0.84 IL1RN (0.44) KDM4EPKMGAATSHRIL1RN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 EP disclosed
US-9284296-B2 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions AUBERGINE PHARMACEUTICALS LLC (US) 2016-03-15 US disclosed
WO-2012069428-A1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA, S.A. (ES) 2012-05-31 WO disclosed